These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 32682418)

  • 1. Identification of potential crucial genes in atrial fibrillation: a bioinformatic analysis.
    Zhang J; Huang X; Wang X; Gao Y; Liu L; Li Z; Chen X; Zeng J; Ye Z; Li G
    BMC Med Genomics; 2020 Jul; 13(1):104. PubMed ID: 32682418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrative transcriptomic, proteomic, and machine learning approach to identifying feature genes of atrial fibrillation using atrial samples from patients with valvular heart disease.
    Liu Y; Bai F; Tang Z; Liu N; Liu Q
    BMC Cardiovasc Disord; 2021 Jan; 21(1):52. PubMed ID: 33509101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of key genes in atrial fibrillation using bioinformatics analysis.
    Liu Y; Tang R; Zhao Y; Jiang X; Wang Y; Gu T
    BMC Cardiovasc Disord; 2020 Aug; 20(1):363. PubMed ID: 32778054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CXCR4 and TYROBP mediate the development of atrial fibrillation via inflammation.
    Zhang YF; Meng LB; Hao ML; Li XY; Zou T
    J Cell Mol Med; 2022 Jun; 26(12):3557-3567. PubMed ID: 35607269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential Target Genes in the Development of Atrial Fibrillation: A Comprehensive Bioinformatics Analysis.
    Liu L; Yu Y; Hu LL; Dong QB; Hu F; Zhu LJ; Liang Q; Yu LL; Bao HH; Cheng XS
    Med Sci Monit; 2021 Mar; 27():e928366. PubMed ID: 33741890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioinformatic gene analysis for potential biomarkers and therapeutic targets of atrial fibrillation-related stroke.
    Zou R; Zhang D; Lv L; Shi W; Song Z; Yi B; Lai B; Chen Q; Yang S; Hua P
    J Transl Med; 2019 Feb; 17(1):45. PubMed ID: 30760287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive Analysis of Pertinent Genes and Pathways in Atrial Fibrillation.
    Wang Y; Cai W; Gu L; Ji X; Shen Q
    Comput Math Methods Med; 2021; 2021():4530180. PubMed ID: 35003319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diversity among differentially expressed genes in atrial appendages of atrial fibrillation: The role and mechanism of SPP1 in atrial fibrosis.
    Wang X; Li H; Zhang A; Zhang Y; Li Z; Wang X; Gao M; Zhang Y; Hou Y
    Int J Biochem Cell Biol; 2021 Dec; 141():106074. PubMed ID: 34474184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and Validation of Autophagy-Related Genes as Potential Biomarkers and Therapeutic Targets in Atrial Fibrillation.
    Zhou J; Dong Y; Cai X; Yang H; Guo T
    Int J Gen Med; 2021; 14():7783-7796. PubMed ID: 34785936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of key differentially expressed immune related genes in patients with persistent atrial fibrillation: an integrated bioinformation analysis.
    Tao Y; Feng T; Zhou L; Han L
    BMC Cardiovasc Disord; 2024 Jul; 24(1):346. PubMed ID: 38977948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of genes and key pathways underlying the pathophysiological association between nonalcoholic fatty liver disease and atrial fibrillation.
    Chu Y; Yu F; Wu Y; Yang J; Shi J; Ye T; Han D; Wang X
    BMC Med Genomics; 2022 Jul; 15(1):150. PubMed ID: 35790963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Genes and Key Pathways Associated with the Pathophysiology of Lung Cancer and Atrial Fibrillation.
    Yang D; Chen Y; Yu Y; Chen X
    Altern Ther Health Med; 2024 Mar; 30(3):68-75. PubMed ID: 37883760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioinformatic analysis for the identification of potential gene interactions and therapeutic targets in atrial fibrillation.
    Yu SD; Yu JY; Guo Y; Liu XY; Liang T; Chen LZ; Chu YP; Zhang HP
    Eur Rev Med Pharmacol Sci; 2021 Mar; 25(5):2281-2290. PubMed ID: 33755965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Pivotal MicroRNAs and Target Genes Associated with Persistent Atrial Fibrillation Based on Bioinformatics Analysis.
    Xiao S; Zhou Y; Liu Q; Zhang T; Pan D
    Comput Math Methods Med; 2021; 2021():6680211. PubMed ID: 33747117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrative analyses of biomarkers and pathways for heart failure.
    Fan S; Hu Y
    BMC Med Genomics; 2022 Mar; 15(1):72. PubMed ID: 35346191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of atrial fibrillation-related genes through transcriptome data analysis and Mendelian randomization.
    Zhang Y; Lian Q; Nie Y; Zhao W
    Front Cardiovasc Med; 2024; 11():1414974. PubMed ID: 39055656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening and Bioinformatics Analysis of Crucial Gene of Heart Failure and Atrial Fibrillation Based on GEO Database.
    Zhuang Y; Qiao Z; Bi X; Han D; Jiang Q; Zhang Y; Wang F; Liu M; An Q; Shangguan J; Shen D
    Medicina (Kaunas); 2022 Sep; 58(10):. PubMed ID: 36295481
    [No Abstract]   [Full Text] [Related]  

  • 18. Identification of Hepatocellular Carcinoma-Related Potential Genes and Pathways Through Bioinformatic-Based Analyses.
    Wan Z; Zhang X; Luo Y; Zhao B
    Genet Test Mol Biomarkers; 2019 Nov; 23(11):766-777. PubMed ID: 31633428
    [No Abstract]   [Full Text] [Related]  

  • 19. Identification of potential novel biomarkers and therapeutic targets involved in human atrial fibrillation based on bioinformatics analysis.
    Fan G; Wei J
    Kardiol Pol; 2020 Aug; 78(7-8):694-702. PubMed ID: 32383373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction and Analysis of the lncRNA-miRNA-mRNA Network Based on Competing Endogenous RNA in Atrial Fibrillation.
    Ke X; Zhang J; Huang X; Li S; Leng M; Ye Z; Li G
    Front Cardiovasc Med; 2022; 9():791156. PubMed ID: 35141302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.